← Open Payments lookup

AMY MILMINE-STEIN: Open Payments

NPI 1942716725 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,140 in 57 payments from 9 companies in 2025. Trend: 2023 $754 · 2024 $1,079 · 2025 $1,140

Food & beverage: $1,140
CompanyPaymentsAmount
Gilead Sciences, Inc.18$440
Ipsen Biopharmaceuticals, Inc9$230
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$171
ABBVIE INC.5$92
Madrigal Pharmaceuticals5$83
Novo Nordisk Inc2$41
Intercept Pharmaceuticals, Inc.2$37
Mallinckrodt Hospital Products Inc.1$27
Mirum Pharmaceuticals, Inc.1$18

Products named: IQIRVO, XIFAXAN, MAVYRET, REZDIFFRA, Wegovy, OCALIVA, TERLIVAZ, Livmarli.

Industry payments across AZ — which companies pay providers there.